Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea
Background The aim of this study was to evaluate clinical outcomes in coronavirus disease 2019 (COVID-19) positive patients with type 2 diabetes compared to those without diabetes in Korea. Methods We extracted claims data for patients diagnosed with COVID-19 from the National Health Insurance Service database in Korea from January 20, 2020 to March 31, 2020. We followed up this cohort until death from COVID-19 or discharge from hospital. Results A total of 5,473 patients diagnosed with COVID-19 were analyzed, including 495 with type 2 diabetes and 4,978 without diabetes. Patients with type 2 diabetes were more likely to be treated in the intensive care unit (ICU) (P<0.0001). The incidence of in-hospital mortality was higher in patients with type 2 diabetes (P<0.0001). After adjustment for age, sex, insurance status, and comorbidities, odds of ICU admission (adjusted odds ratio [OR], 1.59; 95% confidence interval [CI], 1.02 to 2.49; P=0.0416) and in-hospital mortality (adjusted OR, 1.90; 95% CI, 1.13 to 3.21; P=0.0161) among patients with COVID-19 infection were significantly higher in those with type 2 diabetes. However, there was no significant difference between patients with and without type 2 diabetes in ventilator, oxygen therapy, antibiotics, antiviral drugs, antipyretics, and the incidence of pneumonia after adjustment. Conclusion COVID-19 positive patients with type 2 diabetes had poorer clinical outcomes with higher risk of ICU admission and in-hospital mortality than those without diabetes. Therefore, medical providers need to consider this more serious clinical course when planning and delivering care to type 2 diabetes patients with COVID-19 infection..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Endocrinology and Metabolism - 35(2020), 4, Seite 901-908 |
| Sprache: |
Englisch ; Koreanisch |
|---|
| Beteiligte Personen: |
Ji Hong You [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Covid-19 |
|---|
| doi: |
10.3803/EnM.2020.787 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ048425591 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ048425591 | ||
| 003 | DE-627 | ||
| 005 | 20230501185753.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3803/EnM.2020.787 |2 doi | |
| 035 | |a (DE-627)DOAJ048425591 | ||
| 035 | |a (DE-599)DOAJ97cd568aa05f4e0ab6301ecbda947530 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a kor | ||
| 050 | 0 | |a RC648-665 | |
| 100 | 0 | |a Ji Hong You |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background The aim of this study was to evaluate clinical outcomes in coronavirus disease 2019 (COVID-19) positive patients with type 2 diabetes compared to those without diabetes in Korea. Methods We extracted claims data for patients diagnosed with COVID-19 from the National Health Insurance Service database in Korea from January 20, 2020 to March 31, 2020. We followed up this cohort until death from COVID-19 or discharge from hospital. Results A total of 5,473 patients diagnosed with COVID-19 were analyzed, including 495 with type 2 diabetes and 4,978 without diabetes. Patients with type 2 diabetes were more likely to be treated in the intensive care unit (ICU) (P<0.0001). The incidence of in-hospital mortality was higher in patients with type 2 diabetes (P<0.0001). After adjustment for age, sex, insurance status, and comorbidities, odds of ICU admission (adjusted odds ratio [OR], 1.59; 95% confidence interval [CI], 1.02 to 2.49; P=0.0416) and in-hospital mortality (adjusted OR, 1.90; 95% CI, 1.13 to 3.21; P=0.0161) among patients with COVID-19 infection were significantly higher in those with type 2 diabetes. However, there was no significant difference between patients with and without type 2 diabetes in ventilator, oxygen therapy, antibiotics, antiviral drugs, antipyretics, and the incidence of pneumonia after adjustment. Conclusion COVID-19 positive patients with type 2 diabetes had poorer clinical outcomes with higher risk of ICU admission and in-hospital mortality than those without diabetes. Therefore, medical providers need to consider this more serious clinical course when planning and delivering care to type 2 diabetes patients with COVID-19 infection. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a type 2 | |
| 650 | 4 | |a incidence | |
| 650 | 4 | |a mortality | |
| 650 | 4 | |a epidemiology | |
| 653 | 0 | |a Diseases of the endocrine glands. Clinical endocrinology | |
| 700 | 0 | |a Sang Ah Lee |e verfasserin |4 aut | |
| 700 | 0 | |a Sung-Youn Chun |e verfasserin |4 aut | |
| 700 | 0 | |a Sun Ok Song |e verfasserin |4 aut | |
| 700 | 0 | |a Byung-Wan Lee |e verfasserin |4 aut | |
| 700 | 0 | |a Dae Jung Kim |e verfasserin |4 aut | |
| 700 | 0 | |a Edward J. Boyko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Endocrinology and Metabolism |d Korean Endocrine Society, 2016 |g 35(2020), 4, Seite 901-908 |w (DE-627)DOAJ000066575 |x 20935978 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2020 |g number:4 |g pages:901-908 |
| 856 | 4 | 0 | |u https://doi.org/10.3803/EnM.2020.787 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/97cd568aa05f4e0ab6301ecbda947530 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.e-enm.org/upload/pdf/enm-2020-787.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2093-596X |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2093-5978 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2020 |e 4 |h 901-908 | ||